Francis X Mcdermott Net Worth

The estimated Net Worth of Francis X Mcdermott is at least $4.12 Milión dollars as of 30 September 2004. Francis Mcdermott owns over 19,230 units of Balchem stock worth over $4,124,829 and over the last 21 years Francis sold BCPC stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Francis Mcdermott BCPC stock SEC Form 4 insiders trading

Francis has made over 2 trades of the Balchem stock since 2004, according to the Form 4 filled with the SEC. Most recently Francis exercised 19,230 units of BCPC stock worth $367,485 on 30 September 2004.

The largest trade Francis's ever made was exercising 19,230 units of Balchem stock on 30 September 2004 worth over $367,485. On average, Francis trades about 5,758 units every 0 days since 2004. As of 30 September 2004 Francis still owns at least 25,156 units of Balchem stock.

You can see the complete history of Francis Mcdermott stock trades at the bottom of the page.

What's Francis Mcdermott's mailing address?

Francis's mailing address filed with the SEC is , , , , .

Insiders trading at Balchem

Over the last 22 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick a David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.

What does Balchem do?

founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

Complete history of Francis Mcdermott stock trades at Balchem

Balchem executives and stock owners

Balchem executives and other stock owners filed with the SEC include:

• Theodore Harris,
  Chairman of the Board, President, Chief Executive Officer
• Theodore L. Harris,
  Chairman, CEO & Pres
• Martin Bengtsson,
  Chief Financial Officer
• Scott Mason,
  Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products
• William Backus,
  Chief Accounting Officer
• Mark Stach,
  General Counsel, Secretary
• Carl Martin Bengtsson,
  CFO & Treasurer
• James C. Hyde,
  Sr. VP and GM of Human Nutrition & Health
• Mark A. Stach,
  Gen. Counsel & Corp. Sec.
• John Televantos,
  Lead Independent Director
• Daniel Knutson,
  Independent Director
• Matthew Wineinger,
  Independent Director
• Perry Premdas,
  Independent Director
• David Fischer,
  Independent Director
• Paul Coombs,
  Independent Director
• Joyce Lee,
  Independent Director
• Dino A Rossi,
  President and CEO
• Edward Mcmillan,
  Director
• Matthew David Houston,
  General Counsel, Secretary
• Frank Fitzpatrick,
  Corp Controller & Treasurer
• Mary Theresa Coelho,
  Chief Financial Officer
• Monica Vicente,
  
• Olivier Rigaud,
  
• Elaine R Wedral,
  Director
• Richard Allen Bendure,
  Chief Operating Officer
• Francis X Mcdermott,
  Director
• Paul H Richardson,
  VP Research and Development
• Dana E. Putnam,
  VP and General Manager
• Cruce Patricia Siuta,
  Vice President Technology
• Israel Sheinberg,
  Director
• Winston A Samuels,
  Vice President/GM Encapsulates
• Hoyt Jr Ammidon,
  Director
• Kenneth P Mitchell,
  Director
• Robert T Miniger,
  VP/Human Resources
• David F Ludwig,
  Vice President
• James C Hyde,
  Sr. Vice President
• Kathleen B Fish,
  
• Frederic Boned,
  SVP/GM, Human Nutri. & Health
• Martin Luther Reid,
  SVP Chief Supply Chain Officer
• Hatsuki Miyata,
  EVP, Gen. Counsel & Secretary
• Gunsteren Job Leonard Van,
  SVP and GM, Specialty Products
• Michael Robert Sestrick,
  SVP & Chief Technology Officer
• Michael Brent Tignor,
  SVP & Chief HR Officer
• Jonathan Harrison Griffin,
  SVP & GM, Animal Nutrition